The NHLBI Division of Cardiovascular Diseases strategic plan (September 2008) highlighted the need to identify strategies to halt the AF epidemic and its associated morbidity. Recognizing novel triggers of atrial fibrillation (AF) including sleep-disordered breathing (SDB) and autonomic dysfunction is critical, as the incidence of AF is not fully explained by known risk factors. Although >1.1 million polysomnograms (PSGs) are performed annually in the US, all of which include continuous respiratory, EEG and ECG monitoring, information from these signals that may potentially identify patients at risk for future AF is not utilized. Our goal, therefore, is to identify markers from both standard nocturnal PSG scoring and from the new analyses of the PSG ECG channel that predict incident AF. Capitalizing on existing rigorously collected data (PSG including ECG monitoring, biomarkers, etc) and the multicenter infrastructure of a longitudinal cohort study (Outcomes of Sleep Disorders in Older Men Study;n~3000 participants) provides a strategic opportunity to assess the ability of PSG markers to predict individuals at increased risk for clinically adjudicated AF over an 8 year follow-up period. Although our prior cross-sectional work has shown a 2-4 fold higher odds of AF related to SDB (largely central apnea) and a relationship of SDB with both oxidative stress and systemic inflammation, prior reports have not clarified the role of PSG markers including ECG-derived markers as predictors of incident AF and have not characterized underlying linking pathophysiology. The proposed research is designed to: 1) Identify PSG-based SDB phenotypes that predict incident AF, including the relative contribution of central apnea and periodic breathing versus obstructive apnea, and explore mediation by systemic inflammation and oxidative stress, 2) Identify PSG-derived ECG markers of atrial ectopy and autonomic imbalance and evaluate their utility as predictors of incident AF and 3) Develop and test an AF clinical prediction rule incorporating significant PSG and ECG marker AF predictors. Our group is well-positioned to undertake the study aims given our expertise in epidemiology, sleep medicine, biostatistics, electrophysiology, dynamical systems and signal processing.

Public Health Relevance

We expect that an innovative and readily applicable clinical tool utilizing routinely collected data from the PSGs will inform future screening and treatment AF approaches, and thus will be of high clinical impact. This information, collected in a cohort at high risk for AF and its complications is key for developing new strategies to reduce AF-related morbidity and mortality.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21HL108226-01A1
Application #
8243087
Study Section
Cardiovascular and Sleep Epidemiology (CASE)
Program Officer
Twery, Michael
Project Start
2011-12-01
Project End
2013-11-30
Budget Start
2011-12-01
Budget End
2012-11-30
Support Year
1
Fiscal Year
2012
Total Cost
$294,863
Indirect Cost
$107,052
Name
Case Western Reserve University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Relia, Sachin; Thompson, Nicolas R; Mehra, Reena et al. (2018) Depression score changes in response to sleep disordered breathing treatment with positive airway pressure in a large clinic-based cohort. Sleep Breath 22:195-203
Mariani, Sara; Tarokh, Leila; Djonlagic, Ina et al. (2018) Evaluation of an automated pipeline for large-scale EEG spectral analysis: the National Sleep Research Resource. Sleep Med 47:126-136
Raman, Dileep; Kaffashi, Farhad; Lui, Li-Yung et al. (2017) Polysomnographic Heart Rate Variability Indices and Atrial Ectopy Associated with Incident Atrial Fibrillation Risk in Older Community-dwelling Men. JACC Clin Electrophysiol 3:451-460
Lewis, Eldrin F; Wang, Rui; Punjabi, Naresh et al. (2017) Impact of continuous positive airway pressure and oxygen on health status in patients with coronary heart disease, cardiovascular risk factors, and obstructive sleep apnea: A Heart Biomarker Evaluation in Apnea Treatment (HEARTBEAT) analysis. Am Heart J 189:59-67
May, Anna M; Van Wagoner, David R; Mehra, Reena (2017) OSA and Cardiac Arrhythmogenesis: Mechanistic Insights. Chest 151:225-241
Kaw, Roop; El Zarif, Samer; Wang, Lu et al. (2017) Obesity as an Effect Modifier in Sleep-Disordered Breathing and Postcardiac Surgery Atrial Fibrillation. Chest 151:1279-1287
DeMartino, Theresanne; Ghoul, Rawad El; Wang, Lu et al. (2016) Oxidative Stress and Inflammation Differentially Elevated in Objective Versus Habitual Subjective Reduced Sleep Duration in Obstructive Sleep Apnea. Sleep 39:1361-9
Chen, Xiaoli; Wang, Rui; Lutsey, Pamela L et al. (2016) Racial/ethnic differences in the associations between obesity measures and severity of sleep-disordered breathing: the Multi-Ethnic Study of Atherosclerosis. Sleep Med 26:46-53
Walia, Harneet K; Mehra, Reena (2016) Overview of Common Sleep Disorders and Intersection with Dermatologic Conditions. Int J Mol Sci 17:
Walia, Harneet K; Griffith, Sandra D; Thompson, Nicolas R et al. (2016) Impact of Sleep-Disordered Breathing Treatment on Patient Reported Outcomes in a Clinic-Based Cohort of Hypertensive Patients. J Clin Sleep Med 12:1357-1364

Showing the most recent 10 out of 25 publications